Aequo defended the intellectual property rights of the Ukrainian pharmaceutical company “Darnitsa” in a dispute against Lubnypharm JSC and Ukrpatent (PTO office) regarding the recognition of the Citramon (Цитрамон) trademark as well-known in Ukraine.
On January 26, 2022, the Commercial Court of the city of Kyiv decided in favor of Darnitsa and recognized Citramon as a well-known trademark of Darnitsa as of January 1, 1997. As a result, the Ukrainian trademark certificate № 24778 to "Citramon U" (Цитрамон У), owned by Lubnypharm, was cancelled.
"Recognition of Citramon as a well-known trademark in Ukraine in favor of Darnitsa is a consequence of our client's long-term and systematic investment in the promotion and development of this product, which for many consumers is clearly associated with Darnitsa and is one of the most popular pharmaceuticals, including for the treatment of pain syndrome "- comments Aequo partner Tetiana Kudrytska.
Tetiana Kudrytska, Alina Podolyak, Anastasiia Katkalova, and Viktoriia Semenyna have handled the matter.
